PMAM
CEROW

Picton Mahoney Asset Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Picton Mahoney Asset Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,000
Closed -$1K – 1375
2025
Q3 		$1K Hold
75,000
– – ﹤0.01% 1054
2025
Q2 		$1K Hold
75,000
– – ﹤0.01% 955
2025
Q1 		$1K Hold
75,000
– – ﹤0.01% 918
2024
Q4 		$0 Hold
75,000
– – ﹤0.01% 941
2024
Q3 		$1K Hold
75,000
– – ﹤0.01% 829
2024
Q2 		$1K Hold
75,000
– – ﹤0.01% 591
2024
Q1 		$5K Hold
75,000
– – ﹤0.01% 350
2023
Q4 		$1K Hold
75,000
– – ﹤0.01% 425
2023
Q3 		$5K Hold
75,000
– – ﹤0.01% 385
2023
Q2 		$5K Hold
75,000
– – ﹤0.01% 383
2023
Q1 		$3K Hold
75,000
– – ﹤0.01% 475
2022
Q4 		$4K Hold
75,000
– – ﹤0.01% 607
2022
Q3 		$5K Hold
75,000
– – ﹤0.01% 670
2022
Q2 		$8K Hold
75,000
– – ﹤0.01% 778
2022
Q1 		$17K Buy
+75,000
New +$27.9K ﹤0.01% 855

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Picton Mahoney Asset Management's CEROW Position: Q4 2025 in Review

Picton Mahoney Asset Management sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 75,000 shares — an estimated $1K sold.

Picton Mahoney Asset Management first reported a position in CEROW in Q1 2022 and held it in 15 quarters. The position peaked at $17K in Q1 2022. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Picton Mahoney Asset Management reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 75,000 CERo Therapeutics Warrants shares in Q4 2025, an estimated $1K.
  • Picton Mahoney Asset Management first reported a position in CERo Therapeutics Warrants in Q1 2022 and held it in 15 quarters.
  • Picton Mahoney Asset Management's CERo Therapeutics Warrants position peaked at $17K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.